This phase 2 randomized clinical trial evaluates the effects of pazopanib in combination with paclitaxel vs paclitaxel and placebo on survival in patients with recurrent ovarian cancer.
from Cancer via ola Kala on Inoreader http://ift.tt/2jU0Q28
via IFTTT
Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου